Home/Filings/4/0001654954-21-010812
4//SEC Filing

Kennedy Thomas Ronan 4

Accession 0001654954-21-010812

CIK 0001644903other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 2:09 PM ET

Size

11.7 KB

Accession

0001654954-21-010812

Insider Transaction Report

Form 4
Period: 2021-10-01
Kennedy Thomas Ronan
DirectorCEO and CFO
Transactions
  • Exercise/Conversion

    Restricted Stock Unites

    2021-10-0116,6670 total
    Common Stock (16,667 underlying)
  • Award

    Stock Options

    2021-10-01+75,00075,000 total
    Exercise: $0.00From: 2021-10-01Exp: 2026-10-01Common Stock (75,000 underlying)
  • Exercise/Conversion

    Common Stock

    2021-10-01+16,66724,067 total
  • Award

    Common Stock

    2021-10-01+25,00049,067 total
Footnotes (6)
  • [F1]Represents shares of common stock to be issued upon the vesting of restricted stock units which vest on October 1, 2021.
  • [F2]Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units shall vest on January 1, 2022. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2015 Equity Compensation Plan pursuant to the terms of the Executive Employment Agreement dated October 1, 2021, by and between the Issuer and the Reporting Person.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F4]The restricted stock units were granted on October 1, 2021 and vest on October 1, 2022.
  • [F5]The stock options were granted under the 2015 Equity Compensation Plan pursuant to the terms of the Executive Employment Agreement dated October 1, 2021, by and between the Issuer and the Reporting Person. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options vest on October 1, 2022, subject to continued employment on the applicable vesting date.
  • [F6]Not applicable.

Issuer

cbdMD, Inc.

CIK 0001644903

Entity typeother

Related Parties

1
  • filerCIK 0001826452

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 2:09 PM ET
Size
11.7 KB